
DSwiss Inc
93
Recent news items primarily cover other companies and sectors; no direct recent business developments for DSwiss Inc were reported.
- No recent business-specific news for DSwiss Inc was identified in the latest news coverage [N1][N2][N3][N4][N5][N6][N7][N8].
DSwiss Inc operates as a biotech nutraceutical firm providing high-quality health and beauty products including weight management beverages, anti-aging solutions, immune enhancers, functional foods, skincare, personal care, and pet wellness products. The company offers comprehensive OEM and ODM services encompassing formulation, manufacturing, packaging, regulatory licensing, and marketing support. It maintains compliance with Malaysian Ministry of Health and international standards such as GMP, HACCP, JAKIM Halal, ISO, and MESTI. DSwiss has expanded its presence across Asia-Pacific and is exploring global markets including the US and China. The company emphasizes innovation through a dedicated R&D team and a growing expert workforce.
DSwiss Inc is a Nevada-based biotech nutraceutical company specializing in premium health and beauty products, operating through subsidiaries in Seychelles, Hong Kong, and Malaysia. The company offers turnkey private label manufacturing services for nutraceuticals, skincare, personal care, and pet wellness products, emphasizing natural ingredients, quality control, and regulatory compliance. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.
DSwiss Inc's comprehensive end-to-end manufacturing and product development capabilities, combined with its commitment to quality and regulatory compliance, position it well to serve growing demand in health and beauty markets. Its expanding geographic footprint and diversified product portfolio across functional foods, skincare, and pet wellness provide multiple avenues for client engagement and revenue streams. The company's focus on innovation and expert-driven R&D supports continuous product advancement and market relevance.
DSwiss Inc faces challenges including a current ratio below 1.0, indicating potential liquidity constraints. The company operates in competitive health and beauty sectors where differentiation is critical. Limited public financial disclosure and smaller reporting company status may reduce transparency. Expansion into new markets carries execution risks, and reliance on regulatory approvals and compliance adds operational complexity. Market demand fluctuations and supply chain dependencies could impact performance.
DSwiss Inc's moat is built on its vertically integrated turnkey OEM/ODM capabilities, combining premium natural ingredient sourcing, rigorous quality assurance, and regulatory compliance across multiple jurisdictions. Its broad product portfolio spanning nutraceuticals, skincare, personal care, and pet wellness, supported by in-house R&D and expert consultancy, creates barriers to entry. The company's established distribution network in Asia-Pacific and strategic expansion efforts further strengthen its competitive position.
• Liquidity Risk: As of 2026-09-30, the current ratio is 0.91, indicating current liabilities exceed current assets, which may constrain short-term liquidity.
• Regulatory Compliance Risk: The company operates in multiple jurisdictions with strict health and safety regulations; failure to maintain compliance could disrupt operations.
• Market Competition: The health and beauty industry is highly competitive with many established players, posing challenges to market share growth.
• Execution Risk in Expansion: Efforts to expand into new international markets such as the US and China involve operational and regulatory challenges that may affect growth.
Business trends: Expansion of product lines in health, beauty, and pet wellness sectors with geographic growth in Asia-Pacific and global markets.
Execution milestones: Strengthening R&D capabilities, enhancing regulatory compliance, and expanding OEM/ODM client base.
Key risks: Liquidity constraints, regulatory compliance challenges, competitive market pressures, and execution risks in international expansion.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- DSwiss Inc is a Nevada corporation incorporated on May 28, 2015, operating through its wholly-owned subsidiary DSwiss Holding Limited in Seychelles [S1].
- The company and its subsidiaries supply high-quality health and beauty products including weight management beverages, anti-aging solutions, and immune system enhancers [S1].
- Operations are conducted through DSwiss Sdn Bhd in Malaysia, owned via DSwiss (HK) Limited in Hong Kong, which is owned by DSwiss Holding Limited [S1].
- DSwiss Biotech Sdn Bhd, a Malaysian entity focused on biotechnology R&D, became a wholly-owned subsidiary in January 2023 [S1].
- DSwiss specializes in turnkey private label manufacturing (OEM/ODM) for nutraceutical, skincare, and personal care products, offering end-to-end solutions from formulation to packaging and shipping [S1].
- The company emphasizes premium natural ingredients, rigorous quality control, and compliance with Malaysian Ministry of Health regulations and international standards such as GMP, HACCP, JAKIM Halal, ISO, and MESTI [S1].
- Product portfolio includes functional foods, health supplements, skincare, personal care, pet wellness products, natural/traditional medicines, and meal replacement/complete nutrition products [S1].
- DSwiss has expanded its team with industry professionals in nutrition, science, laboratory, customer relations, and operations to drive innovation and product development [S1].
- The company is expanding its market presence in Asia-Pacific countries including Malaysia, Singapore, Indonesia, Hong Kong, Australia, Taiwan, Macau, China, and is exploring global markets including the US and China [S1].
- DSwiss provides expert consultancy and strategic marketing support to clients, helping them with market trends, regulatory licensing, and business growth [S1].
- Financial snapshot as of 2026-09-30 shows cash and equivalents of $388,490, current assets of $459,663, current liabilities of $502,687, resulting in a current ratio of 0.91 and cash ratio of 0.77 [S2].
- Net income reported for the period ending 2026-09-30 was $70,150 with basic and diluted EPS of $0.0003 per share [S2].
- Revenue reported for the period ending 2024-09-30 was $2,125 [S2].
- The company is a smaller reporting company and does not provide certain risk factor disclosures [S2].
Generated 2026-11-17
- S1 | 2026-03-31 | 10-K
- S2 | 2026-11-16 | 10-Q
- N1 | 2026-11-17 | www.nasdaq.com | MindWalk Holdings Corp. Enters into $30.0 million Senior Unsecured Revolving Credit Agreement | https://www.nasdaq.com/articles/mindwalk-holdings-corp-enters-300-million-senior-unsecured-revolving-credit-agreement
- N2 | 2026-11-17 | www.nasdaq.com | MongoDB, Inc. Announces Acquisition of Firebolt Analytics Inc. on November 17, 2026 | https://www.nasdaq.com/articles/mongodb-inc-announces-acquisition-firebolt-analytics-inc-november-17-2026
- N3 | 2026-11-17 | www.nasdaq.com | Service Properties Trust Announces Strategy to Sell 77 Retained Hotels by the End of 2028 | https://www.nasdaq.com/articles/service-properties-trust-announces-strategy-sell-77-retained-hotels-end-2028
- N4 | 2026-11-17 | www.nasdaq.com | Wheat Popping Higher After Ukrainian Strike | https://www.nasdaq.com/articles/wheat-popping-higher-after-ukrainian-strike
- N5 | 2026-11-17 | www.nasdaq.com | Firy Inc. (FIRY) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/firy-inc-firy-q3-2026-earnings-call-transcript
- N6 | 2026-11-17 | www.nasdaq.com | XP Inc. (XP) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/xp-inc-xp-q3-2026-earnings-call-transcript
- N7 | 2026-11-17 | www.nasdaq.com | Soluna Holdings (SLNH) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/soluna-holdings-slnh-q3-2026-earnings-call-transcript
- N8 | 2026-11-17 | www.nasdaq.com | Bridger Aerospace (BAER) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/bridger-aerospace-baer-q3-2026-earnings-call-transcript
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


